Moderna Reports Third Quarter 2024 Financial Results and …
Nov 7, 2024 · The FDA and Moderna have agreed on the pivotal study design. The Company expects to start a pivotal study in the first half of 2025. Moderna Corporate Updates. Expanded the Moderna Executive Committee: Moderna President Stephen Hoge, M.D., has taken on an expanded role, adding new responsibilities overseeing Moderna’s commercial organization.
Moderna Reports Third Quarter 2024 Financial Results and …
Nov 7, 2024 · Reports third quarter revenues of $1.9 billion, GAAP net income of $13 million and GAAP EPS of $0.03 Achieves year-to-date product sales of $2.2 billion; reiterates 2024 expected product sales of ...
Moderna to Report Third Quarter 2024 Financial Results on …
Oct 17, 2024 · Moderna will report its third quarter 2024 financial results and provide a corporate update on Thursday, November 7, 2024. The webcast will be available on the Investors section of the Moderna website.
Moderna Inc (MRNA) Q3 2024 Earnings Call Highlights: Strong …
6 days ago · R&D Expenses: $1.1 billion in Q3 2024, a 2% year-over-year decline. SG&A Expenses: $281 million, a 36% year-over-year reduction. U.S. Market Share: 40% share of retail shots in arms for the COVID ...
Moderna's Q3 Earnings Beat Overshadowed By Vaccine Demand …
5 days ago · On Thursday, Moderna Inc. (NASDAQ:MRNA) reported third-quarter revenue of $1.83 billion, beating the consensus of $1.25 billion. The company attributed the growth to higher sales in the U.S ...
Moderna (MRNA) earnings Q3 2024
Nov 7, 2024 · Moderna said its newest Covid vaccine saw benefits after winning approval in the U.S. three weeks earlier than the last iteration of the shot did in 2023.
Moderna reports surprise profit on higher-than-expected COVID …
Nov 7, 2024 · Moderna still expects to make less from COVID vaccine sales this year than it did in 2023, however, and reaffirmed its 2024 sales forecast of $3 billion to $3.5 billion. The company brought in ...
Moderna’s Q3 2024: Revenue Growth and Strategic Advances
6 days ago · Moderna ( (MRNA) ) has released its Q3 earnings. Here is a breakdown of the information Moderna presented to its investors.Moderna, Inc. is a pioneering biotechnology company specializing in the ...
Quarterly Results - Moderna
Moderna Reports Third Quarter 2024 Financial Results and Provides Business Updates. Reports third quarter revenues of $1.9 billion, GAAP net income of $13 million and GAAP EPS of $0.03. Achieves year-to-date product sales of $2.2 billion; reiterates 2024 expected product sales of …
Moderna stock gains on Q3 beat (update) (MRNA:NASDAQ)
Nov 7, 2024 · Maddie Meyer/Getty Images News. Shares of Moderna (NASDAQ:MRNA) traded ~7% higher in the premarket on Thursday after the company swung back to profits on better-than-expected revenue in Q3 thanks ...